Drug: ARIPIPRAZOLE. Injury: Hospitalisation Quarter: 2016Q3
Total Records: 7 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
104245933 | ARIPIPRAZOLE. | Hospitalisation | OTSUKA | 0.00 | M | 0 | 20160919 | CA |
105789843 | ARIPIPRAZOLE. | Hospitalisation | OTSUKA | 0.00 | M | 0 | 20160919 | CA |
107048595 | ARIPIPRAZOLE. | Hospitalisation | OTSUKA | 0.00 | M | 0 | 20160920 | CA |
125836031 | ARIPIPRAZOLE. | Hospitalisation | JANSSEN | 0.00 | 0 | 20160722 | CA | |
125997711 | ARIPIPRAZOLE. | Hospitalisation | BRISTOL MYERS SQUIBB | 0.00 | M | 0 | 20160727 | US |
127587791 | ARIPIPRAZOLE. | Hospitalisation | FDA-CTU | 16.90 YR | M | 0 | 20160918 | US |
127961101 | ARIPIPRAZOLE. | Hospitalisation | BRISTOL MYERS SQUIBB | 0.00 | F | 0 | 20160929 | US |
Total Records: 7 Number of Pages: 1